Eric Olszewski
@ericolsz
Honestly, a lot of pharma is copycat drugs which are minimally differentiated. I would redirect the billions of dollars going into copycat drugs. Did you know that there are over 200 Ozempic copycats in the FDA pipeline, right now? There is so much money that could be going into novel compounds but instead it's chasing hype.
1 reply
1 recast
7 reactions
Jordan Charters
@jkcharters
It reminds me of the same funding problems that are happening in the nonprofit sector. Large nonprofits get the majority of donations with no measurable increase of impact. We require a paradigm shift in medicine now and not later 🙏
0 reply
0 recast
2 reactions